← Back to Search

Septic Shock Clinical Decision Support for Septic Shock

Waitlist Available
Led By Halden F Scott, MD, MSCS
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up up to 24 hours after emergency department arrival
Awards & highlights

Study Summary

This trial will test a tool to help ER doctors predict septic shock in kids. The goal is to see if the tool leads to better care for sepsis patients.

Eligible Conditions
  • Septic Shock
  • Sepsis
  • Emergency


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 hours after emergency department arrival
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 hours after emergency department arrival for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Patients Receiving Guideline-Concordant Septic Shock Care
Secondary outcome measures
Time to Antibiotics
Other outcome measures
30-Day In-Hospital Mortality
Number of Patients Receiving Intravenous Antibiotics during Emergency Department care
Number of Patients With Septic Shock

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Septic Shock Clinical Decision SupportExperimental Treatment1 Intervention
Emergency Department sites in this arm will have Clinical Decision Support (CDS) alerts active in the Electronic Health Record during clinical ED care of patients with suspected sepsis, in addition to following usual institutional standard of care for sepsis. The CDS will alert providers to patients at high risk for developing septic shock.
Group II: Clinical Diagnosis OnlyActive Control1 Intervention
Emergency Department sites in this arm will follow the institutional standard for sepsis care without Clinical Decision Support. Standard care includes clinical diagnosis of sepsis supported by institutional sepsis education, a sepsis pathway and orderset.

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,748 Previous Clinical Trials
2,162,621 Total Patients Enrolled
Agency for Healthcare Research and Quality (AHRQ)FED
401 Previous Clinical Trials
6,820,417 Total Patients Enrolled
Halden F Scott, MD, MSCSPrincipal InvestigatorUniversity of Colorado, Denver

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this trial still a possibility for prospective participants?

"According to the data sourced from clinicaltrials.gov, this trial is actively seeking enrollees with a first posting date of March 16th 2022 and an updated post on March 17th 2022."

Answered by AI

What is the maximum cohort size for this medical study?

"Affirmative. Clinicaltrials.gov demonstrates that this clinical trial is presently recruiting participants, having been advertised on March 16th 2022 and last modified a day later. Three hundred thousand individuals are required to be enlisted from one medical centre."

Answered by AI
~425 spots leftby May 2025